CompletedPhase 4

Vitamin D Increases Serum Levels of the Soluble Receptor for Advanced Glycation End Products in Women With PCOS

United States79 participantsStarted 2012-07

Plain-language summary

The purpose of this study is to investigate the mechanism that explain the beneficial clinical effect of vitamin D treatment in women with PCOS.

Who can participate

Age range16 Years – 48 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Vitamin D deficient premenopausal women Exclusion Criteria: * Pregnant women * Women during their postpartum period * Breastfeeding women * Women taking any kind of exogenous hormones * Women receiving any form of oral vitamin D replacement

What they're measuring

AMH Levels in Women With PCOS

Timeframe: 8 weeks after completing vitamin D treatment

Trial details

NCT IDNCT03644212

SponsorMaimonides Medical Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2013-09

Results submitted2019-03-12

View on ClinicalTrials.gov More Polycystic Ovary Syndrome trials